MJF-14 proximity ligation assay detects early non-inclusion alpha-synuclein pathology with enhanced specificity and sensitivity

α-Synuclein proximity ligation assay (PLA) has proved a sensitive technique for detection of non-Lewy body α-synuclein aggregate pathology. Here, we describe the MJF-14 PLA, a new PLA towards aggregated α-synuclein with unprecedented specificity, using the aggregate-selective α-synuclein antibody MJFR-14-6-4-2 (hereafter MJF-14). Signal in the assay correlates with α-synuclein aggregation in cell culture and human neurons, induced by α-synuclein overexpression or pre-formed fibrils. Co-labelling of MJF-14 PLA and pS129-α-synuclein immunofluorescence in post-mortem cases of dementia with Lewy bodies shows that while the MJF-14 PLA reveals extensive non-inclusion pathology, it is not sensitive towards pS129-α-synuclein-positive Lewy bodies. In Parkinson's disease brain, direct comparison of PLA and immunohistochemistry with the MJF-14 antibody shows widespread α-synuclein pathology preceding the formation of conventional Lewy pathology. In conclusion, we introduce an improved α-synuclein aggregate PLA to uncover abundant non-inclusion pathology, which deserves future validation with brain bank resources and in different synucleinopathies.

Authors

Institutions

Publication Details

Journal
npj Parkinson s Disease
Published
2024-11-29
DOI
https://doi.org/10.1038/s41531-024-00841-9
Citations
15
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
5.54

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

MJF-14 proximity ligation assay detects early non-inclusion alpha-synuclein pathology with enhanced specificity and sensitivity

Cristine Betzer, YuHong Fu, Sara Elfarrash, Vladimir L. Buchman et al.
15 citations
npj Parkinson s Disease
Parkinson's Disease Mechanisms and Treatments
5.54
article

MJF-14 proximity ligation assay detects early non-inclusion alpha-synuclein pathology with enhanced specificity and sensitivity

Cristine Betzer, YuHong Fu, Sara Elfarrash, Vladimir L. Buchman, Nanna Møller Jensen, Mark Denham, Glenda Margaret Halliday, Hjalte Gram, Poul Henning Jensen, Silvio O. Rizzoli, Lasse Reimer, Zagorka Vitic, Donatus Krah, Ali H. Shaib, Hongyun Li
article en
15 citations

Abstract

α-Synuclein proximity ligation assay (PLA) has proved a sensitive technique for detection of non-Lewy body α-synuclein aggregate pathology. Here, we describe the MJF-14 PLA, a new PLA towards aggregated α-synuclein with unprecedented specificity, using the aggregate-selective α-synuclein antibody MJFR-14-6-4-2 (hereafter MJF-14). Signal in the assay correlates with α-synuclein aggregation in cell culture and human neurons, induced by α-synuclein overexpression or pre-formed fibrils. Co-labelling of MJF-14 PLA and pS129-α-synuclein immunofluorescence in post-mortem cases of dementia with Lewy bodies shows that while the MJF-14 PLA reveals extensive non-inclusion pathology, it is not sensitive towards pS129-α-synuclein-positive Lewy bodies. In Parkinson's disease brain, direct comparison of PLA and immunohistochemistry with the MJF-14 antibody shows widespread α-synuclein pathology preceding the formation of conventional Lewy pathology. In conclusion, we introduce an improved α-synuclein aggregate PLA to uncover abundant non-inclusion pathology, which deserves future validation with brain bank resources and in different synucleinopathies.

npj Parkinson s DiseaseVol. 10(1)
The University of Sydney (AU), Mansoura University (EG), Aarhus University (DK), Danish Technological Institute (DK), Universitätsmedizin Göttingen (DE), University of Göttingen (DE), Cardiff University (GB), Neuroscience Research Australia (AU)
Michael J. Fox Foundation for Parkinson's Research, Aarhus Universitet, Parkinsonforeningen, Neuroscience Research Australia, Deutsche Forschungsgemeinschaft, University of Sydney, Lundbeckfonden, H. Lundbeck A/S, Parkinson Vereniging, National Institutes of Health, National Health and Medical Research Council
Reduced inequalities
Openalex Percentile: Top 3%
Parkinson's Disease Mechanisms and Treatments
5.54
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.